37 related articles for article (PubMed ID: 15042071)
1. RNA interference microarrays: high-throughput loss-of-function genetics in mammalian cells.
Silva JM; Mizuno H; Brady A; Lucito R; Hannon GJ
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6548-52. PubMed ID: 15084744
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry-based functional selection of RNA interference triggers for efficient epi-allelic analysis of therapeutic targets.
Micklem DR; Blø M; Bergström P; Hodneland E; Tiron C; Høiby T; Gjerdrum C; Hammarsten O; Lorens JB
BMC Biotechnol; 2014 Jun; 14():57. PubMed ID: 24952598
[TBL] [Abstract][Full Text] [Related]
3. Three new shRNA expression vectors targeting the CYP3A4 coding sequence to inhibit its expression.
Xu S; Xiao Y; Li L; Yu L; Jiang H; Yu A; Zeng S
Acta Pharm Sin B; 2014 Oct; 4(5):350-7. PubMed ID: 26579404
[TBL] [Abstract][Full Text] [Related]
4. Structural diversity repertoire of gene silencing small interfering RNAs.
Chang CI; Kim HA; Dua P; Kim S; Li CJ; Lee DK
Nucleic Acid Ther; 2011 Jun; 21(3):125-31. PubMed ID: 21749289
[TBL] [Abstract][Full Text] [Related]
5. RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels.
Astier AL; Beriou G; Eisenhaure TM; Anderton SM; Hafler DA; Hacohen N
J Immunol; 2010 Jan; 184(2):685-93. PubMed ID: 20018615
[TBL] [Abstract][Full Text] [Related]
6. RNA viruses redirect host factors to better amplify their genome.
Boguszewska-Chachulska AM; Haenni AL
Adv Virus Res; 2005; 65():29-61. PubMed ID: 16387193
[TBL] [Abstract][Full Text] [Related]
7. Protein degradation via the proteosome.
Hoff H; Zhang H; Sell C
Methods Mol Biol; 2004; 285():79-92. PubMed ID: 15269401
[No Abstract] [Full Text] [Related]
8. Proteasome: a new target of UV radiations.
Nizard C; Bulteau AL; Moreau M; Saunois A; Friguet B
Eur J Dermatol; 2002; 12(6):XXVII-XXVIII. PubMed ID: 12506901
[No Abstract] [Full Text] [Related]
9. A resource for large-scale RNA-interference-based screens in mammals.
Paddison PJ; Silva JM; Conklin DS; Schlabach M; Li M; Aruleba S; Balija V; O'Shaughnessy A; Gnoj L; Scobie K; Chang K; Westbrook T; Cleary M; Sachidanandam R; McCombie WR; Elledge SJ; Hannon GJ
Nature; 2004 Mar; 428(6981):427-31. PubMed ID: 15042091
[TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation.
Henriksen J; Aagesen TH; Maelandsmo GM; Lothe RA; Myklebost O; Forus A
Oncogene; 2003 Aug; 22(34):5358-61. PubMed ID: 12917637
[TBL] [Abstract][Full Text] [Related]
11. The molecular perspective: ubiquitin and the proteosome.
Goodsell DS
Stem Cells; 2003; 21(4):509-10. PubMed ID: 12832704
[No Abstract] [Full Text] [Related]
12. Functional identification of cancer-relevant genes through large-scale RNA interference screens in mammalian cells.
Brummelkamp TR; Berns K; Hijmans EM; Mullenders J; Fabius A; Heimerikx M; Velds A; Kerkhoven RM; Madiredjo M; Bernards R; Beijersbergen RL
Cold Spring Harb Symp Quant Biol; 2004; 69():439-45. PubMed ID: 16117679
[No Abstract] [Full Text] [Related]
13. LMP2 expression and proteasome activity in NOD mice.
Runnels HA; Watkins WA; Monaco JJ
Nat Med; 2000 Oct; 6(10):1064-5; author reply 1065-6. PubMed ID: 11017112
[No Abstract] [Full Text] [Related]
14. RNA interference: human genes hit the big screen.
Fraser A
Nature; 2004 Mar; 428(6981):375-8. PubMed ID: 15042071
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
